AbbVie (NYSE: ABBV) today announced positive results from a new post-hoc analysis from the Measure Up 1 and Measure Up 2 Phase 3 studies. The analysis evaluated the efficacy of upadacitinib (15 mg or ...

Holding parents legally liable for the actions of their children has always been a controversial matter both legally and in ...

People are wearing a common product overnight as a face mask — here's what the skin experts have to say about it.

Jolaoso described the unfounded claim of vaccines “being unsafe or a tool designed to reduce African populations” as lacking ...

Measles often begins as cold-like symptoms including a high temperature, a blocked or runny nose, sneezing and a cough, ...

My husband and I have been preparing him for a while (more than a month, actually), stating the number of days I’ll be gone, ...

A spokesperson said: "Here on the Isle of Man we are seeing a decline in the uptake of the first MMR dose: down from 92 per cent in 2023 to 89 per cent in 2024 and the second MMR dose, down from 78.5 ...

According to the NHS, eczema is a common skin condition that causes dry and itchy rashes. Currently, in the UK around 1.5 million adults have eczema, which amounts to 3% of the population ... Another ...

GSK plc (LSE/NYSE: GSK) today announced positive topline data from the phase 3 trial in adults 50 years and older evaluating the immunogenicity, reactogenicity and safety of AREXVY (Respiratory ...

Alert as childhood vaccination rates fall putting millions at riskA highly contagious virus that can cause miscarriages is ...

PHN is characterised by pain lasting from three months to several years after the rash subsides, and it is also the most ...